News | April 05, 2007

MedicalCV’s Ablation Device Used in Closed-Chest Robotic Cardiac Procedure

April 6, 2007 — MedicalCV Inc., Minneapolis, MN, has announced that Allen R. Raczkowski, M.D., director of Robotic Cardiac Surgery at Banner Baywood Health Systems in Mesa, AZ, performed a closed-chest, robotic, lone cardiac ablation procedure on an arrested heart on March 30 using the ATRILAZE Surgical Ablation System.

"With a clinical history of unsuccessful medical treatment and interventional ablations, this patient was an ideal candidate for a minimally invasive operation. The versatility of the ATRILAZE wand allowed me to create the critical lesion sets with robotic assistance, providing the greatest chance of helping this patient," said Dr. Raczkowski, a leading pioneer in minimally invasive cardiac surgery. "I look forward to utilizing this and additional surgical ablation products from MedicalCV in the future."

The ATRILAZE Surgical Ablation System is a laser-based technology platform that provides cardiac tissue ablation in both open and endoscopic surgeries. The system is FDA cleared for ablation or coagulation of soft tissue, including cardiac tissue, but in the U.S. its use in treating cardiac arrhythmias is specifically excluded. To date, the product has been used in numerous institutions around the country including Baylor University Medical Center, Northwestern University Medical Center, Central DuPage Hospital, Baptist Medical Center in San Antonio, Texas, and Scottsdale Healthcare - Osborn in Arizona.

For more information visit www.medcvinc.com.

Related Content

Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biosense webster multielectrode balloon RF ablation catheter

The Biosense Webster multi-electrode balloon RF ablation catheter. Each electrode can have varied power settings to avoid damage to underlying tissues like the esophagus. 

Feature | EP Lab| June 22, 2017 | Dave Fornell
Electrophysiology (EP) technology has been advancing rapidly the past few years with new ablation tools to improve...
Sponsored Content | Videos | EP Lab| May 26, 2017
DAIC Editor Dave Fornell takes a tour of some of the most innovative new electrophysiology (EP) technology at the 201
Sponsored Content | Videos | Atrial Fibrillation| May 17, 2017
Hugh Calkins, M.D., FACC, FAHA, FHRS, director of cardiac arrhythmia services and professor of medicine at Johns Hopk
Biosense Webster multi-electrode RF ablation balloon

Biosense Webster's multi-electrode RF ablation balloon with irrigation. The system allows operators to change the energy levels of each electrode to avoid damaging sensitive underlying critical structures like the esophagus or phrenic nerve.

Feature | Ablation Systems| May 17, 2017 | Dave Fornell
May 17, 2017 – Clinical trial results from a first-in-human study evaluating the acute feasibility of an investigatio
Large Multicenter Study Shows High Success Rate for Robotic PCI Procedures, SCAI, Corindus CorPath 200
News | Robotic Systems| May 16, 2017
The largest real-world study of robotic percutaneous coronary intervention (PCI) demonstrated clinical and technical...
Abbott Announces CE Mark for New Cardiac Ablation Catheter
News | Ablation Systems| May 10, 2017
Abbott announced CE Mark of the TactiCath Contact Force Ablation Catheter, Sensor Enabled, developed to make it easier...
Overlay Init